FREMONT, Calif.--(BUSINESS WIRE)--AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, announced today that its flagship product, the AngioSculpt® Scoring Balloon Catheter, has received import approval from Japan’s Ministry of Health, Labor and Welfare (MHLW/PMDA) for the interventional treatment of coronary artery disease in that country.
